Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative efficacy and safety of cetylpyridinium chloride + benzydamine lozenges in sore throat associated with upper respiratory tract infections
2011-000278-74Phase 3Completed
- Sponsor
- Krka
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of benzydamine + cetylpyridine chloride in pharyngitis (3 arms), sponsored by Krka. Primary endpoint: Total Pain Relief (TOTPAR 3-180 min). Started Jul 2011; status: completed.
02
Drugs
benzydamine + cetylpyridine chloride
03
Conditions
pharyngitis
Beyond the preview
Go deeper on 2011-000278-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000278-74.